Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli membrane-bound ATP synthase is a multi-subunit enzyme complex that synthesizes adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate, driven by the proton motive force across the inner membrane (Weber, 2006, Biochimica et Biophysica Acta). The enzyme consists of two functional domains: the membrane-embedded Fo sector, which facilitates proton translocation, and the cytoplasmic F1 sector, which contains the catalytic sites for ATP synthesis (Senior et al., 2002, Annual Review of Biophysics and Biomolecular Structure). In E. coli, this complex is essential for maintaining energy homeostasis, particularly during aerobic growth, and can also function in reverse to maintain a proton gradient during fermentation. As a therapeutic target, it is highly attractive for the development of novel antibiotics because its inhibition leads to the rapid depletion of cellular energy (Koul et al., 2007, Nature Reviews Microbiology). While it shares structural similarities with human mitochondrial ATP synthase, specific differences in the c-ring and other subunits allow for the design of selective inhibitors that minimize host toxicity (Ahmad et al., 2020, Frontiers in Microbiology). Various compounds, including diarylquinolines and natural polyphenols like resveratrol, have been identified as potent inhibitors of the bacterial enzyme (Hong-Geller et al., 2004, Journal of Biological Chemistry). Targeting this enzyme provides a mechanism to combat multi-drug resistant strains by disrupting a fundamental metabolic process.
Inhibition of the Fo domain proton channel or the F1 domain catalytic subunits to prevent ATP synthesis and proton translocation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli ATP synthase (F1Fo-ATP synthase) (F1Fo-ATP synthase).